tyrosine kinase inhibitor (Innoventus)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nametyrosine kinase inhibitor (Innoventus)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine kinases inhibitorsInsulin sensitizers
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoventus Project Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoventus Project Ab
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A